Embecta Corp. (EMBC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$9.09
-1.68%
Mkt Cap $546.01M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $258.07M | $261.20M | +1.21% | $0.67 | $0.71 | +5.97% | — | — |
| Q4 2025 Nov 25, 2025 | $258.20M | $264.00M | +2.25% | $0.70 | $0.50 | -28.57% | — | — |
| Q3 2025 Aug 8, 2025 | $265.66M | $295.50M | +11.23% | $0.46 | $1.12 | +146.15% | — | — |
| Q2 2025 May 9, 2025 | $278.78M | $259.00M | -7.09% | $0.66 | $0.70 | +6.06% | — | — |
| Q1 2025 Feb 6, 2025 | $264.40M | $261.90M | -0.95% | $0.45 | $0.65 | +44.44% | — | — |
| Q4 2024 Nov 26, 2024 | $276.97M | $286.10M | +3.30% | $0.36 | $0.45 | +25.00% | — | — |
| Q3 2024 Aug 9, 2024 | $276.97M | $272.50M | -1.61% | $0.48 | $0.74 | +54.17% | — | — |
| Q2 2024 May 9, 2024 | $264.70M | $287.20M | +8.50% | $0.43 | $0.67 | +55.81% | — | — |
| Q1 2024 Feb 9, 2024 | $264.91M | $277.30M | +4.68% | $0.45 | $0.61 | +35.56% | — | — |
| Q4 2023 Nov 21, 2023 | $264.91M | $281.90M | +6.41% | $0.42 | $0.59 | +40.48% | — | — |
| Q3 2023 Aug 8, 2023 | $271.82M | $286.10M | +5.25% | $0.46 | $0.69 | +50.00% | — | — |
| Q2 2023 May 12, 2023 | $262.88M | $277.10M | +5.41% | $0.50 | $0.75 | +50.00% | — | — |
| Q1 2023 Feb 14, 2023 | $262.90M | $275.70M | +4.87% | $0.52 | $0.96 | +84.62% | — | — |
| Q4 2022 Dec 20, 2022 | $261.01M | $274.60M | +5.20% | $0.67 | $0.73 | +8.96% | — | — |
| Q3 2022 Aug 15, 2022 | $276.86M | $291.10M | +5.14% | $0.87 | $1.30 | +49.43% | — | — |
| Q2 2022 May 13, 2022 | — | $274.50M | — | — | $1.38 | — | — | — |
| Q1 2022 Mar 16, 2022 | — | $289.30M | — | — | $1.73 | — | — | — |
| Q4 2021 Nov 14, 2021 | — | $300.50M | — | — | $1.70 | — | — | — |
| Q3 2021 Aug 14, 2021 | — | $295.00M | — | — | $1.84 | — | — | — |
| Q2 2021 May 15, 2021 | — | $284.20M | — | — | $1.89 | — | — | — |